Insider Transactions in Q3 2023 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,255
-27.37%
|
$500,595
$69.54 P/Share
|
|
Sep 29
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,255
+21.49%
|
$261,180
$36.75 P/Share
|
|
Sep 14
2023
|
Wayne Markowitz GM & SVP, Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
7,262
+50.0%
|
-
|
|
Sep 14
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
8,660
-3.89%
|
$632,180
$73.63 P/Share
|
|
Sep 14
2023
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,660
+3.75%
|
$389,700
$45.28 P/Share
|
|
Sep 14
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
4,500
-10.23%
|
$328,500
$73.71 P/Share
|
|
Sep 14
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+9.28%
|
$162,000
$36.75 P/Share
|
|
Sep 08
2023
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
5,000
-12.56%
|
$380,000
$76.0 P/Share
|
|
Sep 08
2023
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.16%
|
$180,000
$36.75 P/Share
|
|
Sep 06
2023
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
8,500
-26.19%
|
$646,000
$76.07 P/Share
|
|
Sep 06
2023
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+20.76%
|
$501,500
$59.26 P/Share
|
|
Sep 05
2023
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-86.74%
|
$2,201,250
$75.86 P/Share
|
|
Sep 05
2023
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+46.45%
|
$1,056,600
$36.75 P/Share
|
|
Aug 31
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,255
-27.37%
|
$558,635
$77.79 P/Share
|
|
Aug 31
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,255
+21.49%
|
$261,180
$36.75 P/Share
|
|
Aug 31
2023
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
49,766
+1.34%
|
-
|
|
Aug 31
2023
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
49,766
-91.73%
|
-
|
|
Aug 29
2023
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
1,500
-5.89%
|
$114,000
$76.69 P/Share
|
|
Aug 14
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
6,421
-2.92%
|
$507,259
$79.3 P/Share
|
|
Aug 14
2023
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
6,421
+2.83%
|
$288,945
$45.28 P/Share
|
|
Aug 14
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
4,500
-10.23%
|
$355,500
$79.3 P/Share
|
|
Aug 14
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+9.28%
|
$162,000
$36.75 P/Share
|
|
Aug 10
2023
|
Heisz Leslie Stone Director |
SELL
Open market or private sale
|
Direct |
3,303
-10.91%
|
$257,634
$78.87 P/Share
|
|
Aug 09
2023
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
5,000
-12.56%
|
$390,000
$78.64 P/Share
|
|
Aug 09
2023
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.16%
|
$180,000
$36.75 P/Share
|
|
Aug 07
2023
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-17.62%
|
$2,348,000
$80.2 P/Share
|
|
Aug 07
2023
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+25.98%
|
$1,056,600
$36.75 P/Share
|
|
Jul 31
2023
|
Bernard J Zovighian CEO |
BUY
Discretionary transaction
|
Direct |
2,558
+5.15%
|
$212,314
$83.54 P/Share
|
|
Jul 31
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,255
-27.37%
|
$609,420
$84.35 P/Share
|
|
Jul 31
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,255
+21.49%
|
$261,180
$36.75 P/Share
|
|
Jul 14
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
8,660
-3.89%
|
$796,720
$92.94 P/Share
|
|
Jul 14
2023
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,660
+3.75%
|
$389,700
$45.28 P/Share
|
|
Jul 14
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
3,500
-8.14%
|
$322,000
$92.94 P/Share
|
|
Jul 14
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+7.53%
|
$126,000
$36.75 P/Share
|
|
Jul 10
2023
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
5,000
-12.56%
|
$450,000
$90.52 P/Share
|
|
Jul 10
2023
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.16%
|
$180,000
$36.75 P/Share
|
|
Jul 07
2023
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.72%
|
$22,680
$90.46 P/Share
|
|
Jul 07
2023
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
81
-0.05%
|
$7,290
$90.46 P/Share
|
|
Jul 05
2023
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-18.86%
|
$2,641,500
$90.92 P/Share
|
|
Jul 05
2023
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+25.98%
|
$1,056,600
$36.75 P/Share
|